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Eukaryotic Okazaki fragments are initiated by a RNA/DNA
primer, which is removed before the fragments are joined.
Polymerase  displaces the primer into a flap for processing.
Dna2 nuclease/helicase and flap endonuclease 1 (FEN1) are
proposed to cleave the flap. The single-stranded DNA-bind-
ing protein, replication protein A (RPA), governs cleavage
activity. Flap-bound RPA inhibits FEN1. This necessitates
cleavage by Dna2, which is stimulated by RPA. FEN1 then
cuts the remaining RPA-free flap to create a nick for ligation.
Cleavage by Dna2 requires that it enter the 5-end and track
down the flap. Because Dna2 cleaves the RPA-bound flap, we
investigated the mechanism by which Dna2 accesses the pro-
tein-coated flap for cleavage. Using a nuclease-defective
Dna2 mutant, we showed that just binding of Dna2 dissoci-
ates the flap-bound RPA. Facile dissociation is specific to
substrates with a genuine flap, and will not occur with an
RPA-coated single strand. We also compared the cleavage
patterns of Dna2 with and without RPA to better define RPA
stimulation of Dna2. Stimulation derived from removal of
DNA folding in the flap. Apparently, coordinated with its
dissociation, RPA relinquishes the flap to Dna2 for tracking
in a way that does not allow flap structure to reform. We also
found that RPA strand melting activity promotes excessive
flap elongation, but it is suppressed by Dna2-promoted RPA
dissociation. Overall, results indicate that Dna2 and RPA
coordinate their functions for efficient flap cleavage and
preparation for FEN1.
Eukaryotic DNA replication involves synthesis of a leading
strand in the direction of parental DNA unwinding, and
because of the anti-parallel structure of DNA, a lagging strand
in the opposite direction of unwinding. Although leading
strand synthesis occurs continuously, the lagging strand must
be synthesized in a discontinuous fashion. Lagging strand syn-
thesis is initiated by the polymerase (pol)3 -primase complex,
which synthesizes 8–12 nucleotides (nt) of RNA followed by
20-nt of DNA (1, 2). The pol -primase complex is then
replaced by a complex of the toroidal sliding clamp proliferat-
ing cell nuclear antigen andpol , which is loaded onto theDNA
by the clamp loader replication factor C. This complex synthe-
sizes another 100–150 nt of DNA before the primer terminus
encounters the previously synthesized downstream segment.
These segments, known as Okazaki fragments, must then be
processed to create a continuous strand of DNA. Because pol 
does not possess proofreading activity and synthesizes with rel-
atively low fidelity compared with pol , it is proposed that the
entire RNA/DNA primer, laid down by pol , is removed to
maintain genome integrity (3). Processing of the RNA/DNA
primer is initiated when strand displacement synthesis, by pol
, raises the primer into a single-stranded (ss) flap intermediate
(4–6). Removal of this flap intermediate followed by fragment
joining is known as Okazaki fragment processing.
Several modes of Okazaki fragment processing have been
proposed to occur in Saccharomyces cerevisiae, based on bio-
chemical and genetic data. One involves complete flap removal
by flap endonuclease 1 (FEN1) (4, 7). FEN1 is a structure-spe-
cific nuclease that cleaves at the base of 5 flap intermediates to
create a nick (8). In this mode, pol  displaces the RNA/DNA
primer into short flap intermediates. These flaps are efficiently
cleaved by FEN1. The resultant nicked product is then ligated
by DNA ligase I.
In another proposedmode, cleavage by the nuclease/helicase
Dna2precedes FEN1 cleavage to create a nicked product (9, 10).
When flaps reach a length of 20–30-nt, they are stably boundby
replication protein A (RPA) (11–13). RPA binding prevents
cleavage by FEN1 while stimulating Dna2 cleavage, necessitat-
ing initial flap cleavage by Dna2 (9). Dna2, unlike FEN1, cannot
create a nick product for ligation. Instead, it leaves a short,
5-nt flap devoid of RPA. FEN1 can then cleave this short flap,
creating a nick for ligation by DNA ligase I.
Recent work from our group suggests that both pathways are
employed during flap processing (14). By reconstructing Oka-
zaki fragment processing in vitro, we recently demonstrated
that pol  displaces mostly short flaps (10-nt), which are
readily cleaved by FEN1. In addition to the short flaps, a minor
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subset of longer flaps (10–30-nt) arises, which can be bound by
RPA, requiring the Dna2/FEN1 pathway. These results suggest
that the two pathways work in parallel to resolve Okazaki frag-
ments during DNA replication.
S. cerevisiaeDna2 was identified during a screen for mutants
defective in DNA replication (15, 16). It is an essential protein
possessing both ssDNAendonuclease activity and 5 to 3ATP-
dependent helicase activity (15, 17). In addition, it physically
and genetically interacts with FEN1, further implicating it in
lagging strand replication (18). Recently, Dna2 was shown to
possess strand annealing and strand exchange activities, which
may aid in the formation of a 5 flap intermediate during flap
equilibration (19). Dna2 has subsequently been shown to inter-
act with other proteins involved in DNA replication, including
Pol32, RNase H2, Sgs1, and Exo1 (20). Furthermore, RPA was
found to interact with Dna2 to stimulate both its nuclease and
helicase activities, and the overexpression of RPA overcame the
temperature-sensitive growth of several Dna2mutant alleles (9,
21, 22).
S. cerevisiae RPA is a heterotrimeric protein consisting of
subunits Rpa1–3, each of which is essential in yeast (23–25). In
humans, RPA is also necessary for the reconstitution of SV40
DNA replication (26). Its primary role is to stabilize ssDNA,
preventing it from re-annealing or forming secondary structure
during DNA replication, repair, and recombination (27–29).
Dna2 was shown to interact specifically with Rpa1, the large
subunit of RPA (22). Contacts between the two proteins were
found to occur at both the N- and C-terminal domains of both
Dna2 and Rpa1. Additionally, wild type Dna2 and RPA were
shown to form a complex on a DNA flap substrate (9).
We previously reported that to exhibit nuclease activity,
Dna2 must enter the free 5-end of a flap, and then track down
the flap toward the base for cleavage (30). Accordingly, the
tracking requirement of Dna2 necessitates that it encounter
bound RPA molecules as it moves for successive cleavages.
BecauseDna2 is stimulated for cleavage on flaps coated byRPA,
we were prompted to ask why the presence of RPA does not
interfere with the tracking motion of Dna2. This question is
particularly interesting because Dna2 cleavage is inhibited on
flaps coated by other ssDNA-binding proteins (Escherichia coli
single-stranded binding protein and human RPA) (9, 31). In the
current study, we explored the mechanism by which Dna2
cleaves on RPA-coated flaps, and the manner by which RPA
stimulates Dna2 cleavage activity.
EXPERIMENTAL PROCEDURES
Materials—Synthetic oligonucleotides, including the 5-bio-
tin and 3-biotin conjugations, were produced by Integrated
DNA Technologies. Radionucleotides [-32P]dCTP and
[-32P]ATP were obtained from PerkinElmer Life Sciences.
The Klenow fragment of E. coli DNA polymerase I, polynucle-
otide kinase, streptavidin, and ATP were from Roche Applied
Science. All other reagents were the best available commercial
grade.
Enzyme Expression and Purification—S. cerevisiae Dna2 was
cloned into the Sf9 baculovirus expression vector (Invitrogen).
S. cerevisiaeDna2E675Awas created by site-directedmutagen-
esis as described (32). Both Dna2 wild type and E675A were
then expressed and purified as described (32), except that High
Five cells were utilized. S. cerevisiae RPA (33) and human RPA
(13) were overexpressed and purified as previously described.
Oligonucleotides—Substrate primer sequences are listed in
Table 1. Downstream primers were labeled at either the 3 ter-
minus or the 5 terminus with [32P], as indicated in the figures.
[-32P]dCTPwas incorporated into the 3 terminus by the Kle-
now enzyme and [-32P]ATP was incorporated at the 5 termi-
nus using polynucleotide kinase. After labeling, substrates were
purified as described previously (34). DNA flap substrates were
then annealed in 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, and 1
mM dithiothreitol and in a 1:2:4 ratio of downstream to tem-
plate to upstream primer. The G calculations for the flap
structure were done by entering the unannealed portion of the
primer sequence intomfold, for analysis under reaction condi-
tions (35, 36).
Gel Shift Assay—The reaction volume was 20 l, which con-
tained 5 fmol of labeled substrate and various amounts of pro-
TABLE 1
Oligonucleotides (5-3)
Primer Length (nt) Sequence
Downstreama,b
D1 76 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GCC GTC GTT TTA CAA CGA
CGT GAC TGG G
D2 76 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GCC GTC GTT TTA CAA CGA
CGT GAC TGG G
D3 50 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GC
D4 53 TTC ACG CCT GTT AGT TAA TTC ACT GGC CGT CGT TTT ACA ACG ACG TGA CTG GG
D5 53 TTC ACG CCT GTT AGT TAA TTC ACT GGC CGT AGT TTT ACA ACG ATG TGA CTA AA
D6 53 TTT TTT TTT TTT TTT TTT TTT TTT TCC ACC CGT CCA CCC GAC GCC ACC TCC TG
D7 55 AGG TCT CGA CTA ACT CTA GTC GTT GTT CCA CCC GTC CAC CCG ACG CCA CCT CCT G
D8 97 TTT TTT TTT TTT AGG TCT CGA GGC CTG CTC TAT TAT GAG CAG GCC TCG AGA CCT ACG TAG AGC TGT
TTC CCA CCC GTC CAC CCG ACG CCA CCT CCT G
Upstream
U1 28 CGC CCA GGG TTT TCC CAG GTC ACG GAC A
U2 26 CGA CCG TGC CAG CCT AAA TTT CAA TA
Template
T1 49 GCC CAG TCA CGT CGT TGT AAA ACG GGT CGT GAC TGG GAA AAC CCT GGC G
T2 49 GTT TAG TCA CAT CGT TGT AAA ACT GGT CGT GAC TGG GAA AAC CCT GGC G
T3 54 GCA GGA GGT GGC GTC GGG TGG ACG GGT GGA TTG AAA TTT AGG CTG GCA CGG TCG
a Bolded nucleotides are biotinylated.
b Underline indicates foldback region.
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tein, as indicated. The reaction buffer consisted of 50 mM Tris-
HCl, pH 8.0, 2 mM dithiothreitol, 30 mM NaCl, 0.1 mg/ml
bovine serum albumin, 5% glycerol, 2 mM MgCl2, and 1 mM
ATP, unless otherwise stated. RPA was pre-bound for 5 min at
room temperature followed by addition of Dna2 E675A for 5
min at room temperature. In Figs. 3 and 4, the streptavidin was
preincubated with the substrate for 10 min at 37 °C. For meas-
urement of the dissociation constants in Table 2, the substrate
concentrationwas lowered to 1 fmol (50 pM). All reactionswere
then loaded on pre-run 5% polyacrylamide gels in 0.5 TBE
(Invitrogen). Gels were then subjected to electrophoresis at 150
V for 30–45 min.
Nuclease Assay—Reactions were performed at 37 °C for 10
min. The reaction volume was 20l, which contained 5 fmol of
labeled substrate and various amounts of protein, as indicated.
The reaction buffer consisted of 50 mMTris-HCl, pH 8.0, 2 mM
dithiothreitol, 30mMNaCl, 0.1mg/ml bovine serum albumin, 2
mMMgCl2, and 1mMATP, unless otherwise stated in the figure
legends. The reactions were stopped by addition of 2 termi-
nation dye, consisting of 90% formamide (v/v), 10 mM EDTA,
0.01% bromphenol blue, and 0.01% xylene cyanol. A 15% poly-
acrylamide gel, containing 7 M urea, was then used to separate
the reactions.
Strand Melting Assay—RPA strand melting was measured
using native gel electrophoresis. The reaction buffer consisted
of 50 mM Tris-HCl, pH 8.0, 2 mM dithiothreitol, 30 mM NaCl,
0.1mg/ml bovine serum albumin, and 5% glycerol with or with-
out 1 mM ATP and 2 mM MgCl2, as indicated in the figure
legends. Substrates (5 fmol) were incubated with various
amounts of RPA at 37 °C for 15 min. Reactions were then
stopped by addition of a 6 helicase dye, containing 30% glyc-
erol, 50 mM EDTA, 0.9% SDS, 0.25% bromphenol blue, and
0.25% xylene cyanole. Reactions were then loaded onto 5%
polyacrylamide gels in 0.5 TBE (Invitrogen). Gels were then
subjected to electrophoresis at 150 V for 30 min.
Gel Analysis—Experiments were done in at least duplicate
and representative gels are shown. After running conditions,
gels were transferred to filter paper (Whatman) and dried on a
gel dryer (Bio-Rad) with vacuum (Savant). Gels were then
exposed to a phosphorscreen and analyzed by phosphorimag-
ing (GEHealthcare). Analysis of the image was then performed
using ImageQuantMac, version 1.2.
Calculation of Dissociation Constants—After gel shift analy-
sis, curves were fit using nonlinear least squares regression of
the hyperbolic equation,
y  Bmax  protein/Kd protein	
where y is the percent of oligonucleotide bound, [Protein] is the
concentration of protein in nM, Bmax is the maximum binding,
and Kd is the equilibrium dissociation constant.
RESULTS
Dna2 Removes Flap-bound RPA—Because Dna2 is necessary
to cleave flaps bound by RPA, we planned to determine the
mechanism by which Dna2 gains access to the flap. Previously,
it had been proposed that RPA dissociates as a consequence of
flap cleavage by Dna2 (9). However, another possibility is that
Dna2 dissociates RPA from the flap to gain access to binding
sites for tracking and cleavage. To distinguish these hypotheses,
we tested the ability of the nuclease-defective mutant Dna2
E675A to dissociate RPA. This mutant Dna2 would allow us to
establish whether RPA dissociation depends on cleavage. Reac-
tions employed a double flap substrate with a 53-nt flap. RPA
was pre-bound to the substrate prior to the addition of Dna2
E675A (see “Experimental Procedures”). Pre-binding of RPA
allowed us to observe the subsequent effects of Dna2 addition
on flap-bound RPA. Saturating amounts of RPA were pre-
bound to the flap so that we could assess Dna2 binding to RPA-
bound flaps, without having to simultaneously interpret results
of Dna2 binding to naked flaps. Gel shift analysis was then car-
ried out to determinewhetherDna2 and/or RPAwere bound to
the labeled flap substrate (Fig. 1).
We previously demonstrated that although the Dna2 E675A
mutant is devoid of nuclease activity, it retains both substrate
binding and helicase activities (34). These properties of the
Dna2 E675A allowed us to also assess the effects of helicase
function on Dna2 binding to the RPA-coated substrate. To
accomplish this assessment, binding reactions were carried out
in the presence or absence of ATP, which is required for Dna2
helicase function.
With RPA alone (Fig. 1), the major band in lanes 2 and 9
corresponds to the binding of two RPA molecules to the 53-nt
flap, with the minor band corresponding to one RPAmolecule.
This interpretation is consistent with the banding pattern
changes seen in an RPA concentration titration on the same
substrate, which showedbinding of oneRPAand then two (data
not shown). Dna2 was then titrated into the reaction. As the
amount of Dna2 increased, we observed a shift from an RPA-
bound band to a Dna2-bound band (Fig. 1, lanes 3–6 and
10–13). Similar results were observed on 37- and 30-nt flap
substrates (data not shown). These results are consistent with
the idea that Dna2 removes RPA from the flap in a cleavage
FIGURE 1.Dna2dissociates RPA from flap substrates.Gel shift analysiswas
performed with 100 fmol of RPA, 5 fmol of a 53-nt flap substrate (D2:U1:T1),
and increasingamountsofDna2E675A (50, 100, 200, and500 fmol). Lanes 1–7
contain no ATP and lanes 8–14 contain 1 mM ATP. RPA was pre-bound to the
substrate as indicated under “Experimental Procedures.” Dna2 was then added
into the reaction (lanes 3–6 and 10–13). Lane 1 and 8 are the substrate alone.
Lanes 2 and 9 are substrate with RPA (100 fmol) alone and lanes 7 and 14 are
substrate with Dna2 (500 fmol) alone. The substrate used is depicted above
the gel and the asterisk indicates the site of the 3-32P radiolabel.
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independent manner, allowing Dna2 access to the flap for
cleavage. However, the results do not exclude the possibility
that Dna2 cleavage activity aids in further destabilizing RPA
binding to the flap.
Interestingly, the addition of ATP did not significantly alter
the shift to the Dna2-bound flap (Fig. 1, compare lanes 3–6 and
10–13). However, we observed a minor accumulation of a
super-shifted product, in the presence of both Dna2 and RPA
(lane 6). This product likely represents an intermediate in
which both Dna2 and RPA are bound to the flap substrate.
Because ATP is thought to aid Dna2 tracking on the flap (30),
the absence of ATP might slow RPA removal because tracking
is impaired.
RPA Binds Flaps with a Higher Affinity Than That of Dna2—
To assure that Dna2 replacement of RPA (Fig. 1) was derived
from an active dissociation process and was not based on a
simple difference between binding affinities, we compared the
dissociation constants of RPA and Dna2 (Table 2). Increasing
amounts of Dna2 or RPA were bound to a fixed amount of the
labeled 53-nt flap substrate. Gel shift analysis was then per-
formed to assess binding. The data were then fit by nonlinear
least squares regression to determine relative binding affinities
(Table 2). The substrate concentration was lowered to assure
equilibrium binding (see “Experimental Procedures”). The dis-
sociation constant for RPA binding to a 50-nt segment of
ssDNAwas previously measured to be0.15 nM (37). Here, we
measured the dissociation constant of RPAbinding to the 53-nt
flap substrate to be 0.35 nM. Both wild type Dna2 and Dna2
E675A were tested and found to have dissociation constants of
5.5 and 3.4 nM, respectively (Table 2). When compared with
RPA binding, Dna2 bound with an 10-fold lower relative
binding affinity. In our binding titration in Fig. 1, the concen-
tration of Dna2 never exceeded 5 times the concentration of
RPA. Nevertheless, Dna2 displaced virtually all of the RPA.
These observations suggest that, based on binding affinities,
Dna2 would not have out-competed RPA for binding. Instead,
it must have interacted with RPA in a specific manner to disso-
ciate the higher affinity RPA.
Removal of RPA Is Species-specific—Previously, Kim et al. (9,
31) demonstrated that stimulation of Dna2 by RPA is species-
specific; for example, human RPA (hRPA) inhibits instead of
stimulates S. cerevisiae Dna2 cleavage activity. Using the 53-nt
flap, we also saw inhibition of yeast Dna2 cleavage activity by
hRPA (Fig. 2A). Because Dna2 dissociates RPA (Fig. 1), we
tested whether dissociation is also species-specific (Fig. 2B).
Yeast RPA (lanes 2–4) and hRPA (lanes 6–8) were pre-bound
to the flap. When progressively greater amounts of yeast Dna2
were then incubatedwith the hRPA-bound flaps the quantity of
bound hRPA was unaltered (lanes 6–8). The inability of yeast
Dna2 to remove hRPA from the flap might explain why single-
stranded binding proteins from other species inhibit Dna2
cleavage. If the binding proteins block either the motion or
catalytic activity of Dna2 then cleavage would be prevented.
These data further suggest a specific protein-protein interac-
tion between Dna2 and RPA, which is required for RPA
removal followed by Dna2 cleavage.
Dna2 Tracking Is Not Required for RPA Removal—Dna2
employs a tracking mechanism to cleave on flap substrates. If
the 5-end of the flap is blocked by a double-stranded region or
a streptavidin-biotin conjugate then cleavage is inhibited (30).
Significantly, a block to tracking inhibits cleavage by Dna2, but
not Dna2 binding. Previously, we showed that Dna2 bound a
flap substrate blocked at the 5-end by a streptavidin-biotin
conjugate (34). Because Dna2 can bind the flap without track-
ing, we asked whether it could still remove RPA when the
5-end of the flap was blocked (Fig. 3). Streptavidin was prein-
cubated with a flap containing a biotin attached to the 5-end.
RPA was added into the reaction and allowed to bind the
blocked substrate. Increasing amounts of Dna2 were then
added into the reaction. Surprisingly, Dna2 was still able to
remove the flap-bound RPA even when tracking was blocked
(Fig. 3, lanes 4–6). The ability of Dna2 to remove RPA on sub-
strates blocked at the 5-end is an additional confirmation that
cleavage is not required for the dissociation of RPA.
RPA/Dna2 Interaction Differs on ssDNA—To further analyze
themechanismofRPA removal, we evaluated the effect ofDna2
on RPA bound to a single-stranded segment of DNA (Fig. 4).
Use of ssDNA allowed us to determine whether structural fea-
FIGURE 2. Yeast Dna2 cannot dissociate human RPA. A, Dna2 (50 fmol)
cleavage activity was measured by denaturing PAGE with increasing
amounts of hRPA (10, 50, 100, 200, and 500 fmol) and 5 fmol of the 53-nt flap
substrate (D1:U1:T1). B, gel shift analysis was performed with 100 fmol of
either RPA (lanes 2–4) or hRPA (lanes 6–8), 5 fmol of the 53-nt flap substrate
(D1:U1:T1), and increasing amounts of Dna2 E675A (100 and 200 fmol). RPA
was pre-bound to the substrate as indicated under “Experimental Proce-
dures.” Dna2 was then added into the reaction (lanes 3–4 and 7–8). Lanes 1
and 5 are the substrate alone and substrate with Dna2 E675A (500 fmol)
alone, respectively. The substrate, used is both A and B, is depicted above the
gel in A, and the asterisk indicates the site of the 5-32P radiolabel.
TABLE 2
Relative binding constants
Protein Kda
nM
RPA 0.35
 0.10
Dna2 WT 5.5
 0.77
Dna2 E675A 3.4
 0.50
a Apparent dissociation constants measured by gel shift anlaysis. Results are an
average of two independent experiments.
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tures of the flap are required for RPA dissociation. A biotin was
attached to the 3-end of the ssDNA, because blocking the end
may prevent Dna2 from tracking off the DNA. The 50-nt
sequence used was the same sequence as the 53-nt flap minus
three nucleotides at the 5-end. (These nucleotides were omit-
ted because of a length requirement for 3-biotinmodification.)
The ssDNAwas prepared with and without pre-bound strepta-
vidin. RPA was then bound to the substrate followed by the
addition of Dna2 and the products were then analyzed by gel
shift (Fig. 4).
Dna2 binding to the ssDNA produced two bands, which
likely correspond to one and two molecules of Dna2 bound to
DNA (Fig. 4, lane 7). The presence of streptavidin slowed the
migration of both bands corresponding to bound Dna2, as
anticipated (lane 14). The shift observed when RPA was bound
to the ssDNA (compare lanes 2 and 9) was similar with and
without streptavidin. By titrating progressively more RPA with
the ssDNA, we found that the similar shift resulted from the
binding of only twoRPAmoleculeswhen streptavidinwas pres-
ent versus three in its absence (data not shown). When Dna2
was titrated into the reaction with the bound RPA in Fig. 4, we
were surprised to find that the Dna2 did not shift the labeled
ssDNA to a position that would indicate Dna2 displacement of
the RPA (lanes 3–6, 10–13). Instead, the initial RPA band was
super-shifted to a higher mobility complex. This shift likely
corresponds to the binding of bothDna2 and RPA. The shifting
pattern was not significantly altered by the presence or absence
of streptavidin (compare lanes 1–7 and 8–14). In addition, the
conversion from an RPA band to the super-shifted band was
incomplete at the highest Dna2 concentration with ssDNA,
whereas the same concentration of Dna2 achieved almost com-
plete RPA dissociation with the flap substrate (compare Fig. 4,
lanes 6 and 13, to Fig. 1, lanes 6 and 13). From these results it is
difficult to assess how Dna2 and RPA might interact and bind
the ssDNA. It is readily apparent, however, that the interactions
of RPA and Dna2 on ssDNA are different from those on a flap
substrate (compare Figs. 4 and 1).
RPA Stimulates Dna2 to CleaveMore Efficiently and Past the
Flap Base—We expected that detailed examination of the
effects of RPA interaction on the catalytic activities of Dna2
would revealmore about themovements of bothDna2 andRPA
on flaps. Previous studies have shown RPA stimulation of both
Dna2 helicase and cleavage activities (9, 10). To further exam-
ine the manner in which RPA stimulates Dna2 cleavage, we
analyzed the cleavage patterns of Dna2 with and without RPA.
Because Dna2 cleaves multiple times on the DNA and must
enter at the 5-end for tracking and cleavage (17, 30, 38), we
could visualize both the first and last cleavage sites of Dna2 by
radiolabeling the flap substrates at either the 5- or 3-end of the
flap-primer, respectively. Denaturing PAGE was used to deter-
mine the location of the first cleavage site (5 radiolabel) and the
last cleavage site (3 radiolabel) (Fig. 5). When comparing the
cleavage patterns with and without RPA present, we saw a shift
in cleavage with respect to both the first and last sites. It is
interesting to note that the stimulation of Dna2 cleavage activ-
ity by RPA is lower on the 30-nt flap substrate that we employed
than has been previously observed with other substrates (9, 10,
38). The stimulation by RPA is about 2-fold or less, a value that
will be addressed later under “Results” (Fig. 7). In Fig. 5A, the
first cleavages by Dna2 were distributed along the length of the
flap. The distribution was shifted upon the addition of RPA
(Fig. 5A, lanes 4–7), with the first cleavages occurring closer to
FIGURE 3.Dna2 trackingmechanism is not required for RPAdissociation.
Gel shift analysis was performedwith 100 fmol of RPA, 5 fmol of the 53-nt flap
substrate (D2:U1:T1), and increasing amounts of Dna2 E675A (100, 200, and
500 fmol). The substrate was incubated with streptavidin (250 fmol) prior to
pre-binding with RPA as indicated under “Experimental Procedures.” Dna2
was then added into the reaction (lanes 4–6). Lanes 1–3 are the substrate
alone, substrate with Dna2 E675A (500 fmol) alone, and substrate with RPA
(100 fmol) alone, respectively. The substrate is depicted above the gel. The
asterisk indicates the site of the 3-32P radiolabel, and B indicates the 5biotin.
FIGURE 4. ssDNA alters Dna2 dissociation of RPA. Gel shift analysis was
performedwith100 fmolof RPA, 5 fmolof the50-nt ssDNAsubstrate (D3), and
increasing amounts of Dna2 E675A (50, 100, 200, and 500 fmol). In lanes 8–14,
the substratewas incubatedwith streptavidin (250 fmol) prior to pre-binding
with RPA as indicated under “Experimental Procedures.” Dna2 was then
added into the reaction (lanes 3–6 and 10–13). Lanes 1, 2, and 7 are the sub-
strate control alone, substrate with Dna2 E675A (500 fmol) alone, and sub-
stratewith RPA (100 fmol) alone, respectively,without streptavidin. Lanes 8, 9,
and 14 are the substrate alone, substrate with Dna2 E675A (500 fmol) alone,
and substrate with RPA (100 fmol) alone, respectively, with streptavidin. The
substrate is depicted above the gel. The asterisk indicates the site of the 5-32P
radiolabel, and B indicates the 3 biotin.
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the 5-end of the flap. This result suggests that Dna2 becomes
more efficient at cleavage once it begins tracking onto the
5-end of the flap substrate, because the bound RPA stimulates
Dna2. Alternatively, the Dna2 cleavage pattern could simply be
shifted because RPA binding to the flap decreases the amount
of exposed DNA accessible to Dna2 for cleavage.
Next we examined the final cleavage site positions (Fig. 5B).
When Dna2 alone was incubated with the flap substrate the
furthest cleavage site occurred near the base of the flap (lane 3).
Upon addition of RPA, the cleavage distribution was shifted
further down the flap.Not onlywere the sites of cleavage shifted
closer to the base of the flap but cleavagewas also increased past
the flap base into the originally annealed portion of the primer
(Fig. 5B, lanes 4–7).
Previously, Dna2 was shown to cleave past the flap base in
high ATP concentrations and RPA had also been shown to
stimulateDna2 helicase function (10, 21, 32, 38). Based on these
data, we presumed that the shift further down the flap and into
the originally annealed region was caused by RPA stimulation
of Dna2 helicase activity. To test this expectation, Dna2 and
RPA were incubated in the absence of ATP on the 30-nt flap
substrate (data not shown). We were surprised to see that the
cleavage patterns were the same as those in Fig. 5B. To assure
that no residual ATPwas purified withDna2, we performed the
same experiment with the helicase-deficient mutant Dna2
K1080E (Fig. 5C) and still found cleavage further down the flap
and into the annealed region in the presence of RPA. This
suggests that cleavage into the originally annealed portion of
the primer derives from a property
of RPA and not Dna2 helicase
function.
RPA Strand Melting Facilitates
Dna2 Cleavage—Because RPA is
known to have strandmelting activ-
ity (39), we wondered whether
cleavage into the originally annealed
region occurred because the RPA
melted the double strands near the
flap base. To test this idea, increas-
ing amounts of RPAwere incubated
with the 30-nt flap substrate, used in
Fig. 5. The reaction products were
then resolved by non-denaturing
PAGE (Fig. 6A). RPA was able to
fully displace the radiolabeled flap-
primer in a protein concentration-
dependent manner (Fig. 6A). The
annealed portion of this flap had a
GC-content of 52% (see Table 1).
AT-rich regions have previously
been shown to promote RPA strand
melting activity (40). Accordingly,
we tested several other flap sub-
strates with a 75% GC content in
the annealed region. These sub-
strates exhibited virtually no RPA-
induced unwinding nor Dna2 cleav-
age past the flap base in the presence
of RPA (data not shown and Fig. 7A).
RPA strand melting is suppressed by increased magnesium
concentration (41). Because the experiments in Fig. 6A were
done in the absence of MgCl2 and ATP, we tested whether
unwinding would still occur under more physiological condi-
tions (2 mM MgCl2 and 1 mM ATP). Consistent with previous
studies, RPA strand melting was inhibited on the 30-nt flap
substrate, used in Fig. 6A, whenMgCl2 and ATP were added to
the reaction (Fig. 6B). Although RPA strandmelting was inhib-
ited, the assay only measured the complete removal of the
primer and so did not account for partial melting. Partial melt-
ing of the primer would account for Dna2 cleavage at sites past
the original base of the flap as we observed (see Fig. 5, B andC),
even though the primer was not completely removed when
MgCl2 and ATP were present (Fig. 6B).
Because RPA strand melting was more active on AT-rich
regions of DNA (40), we altered the nucleotide composition to
increase the amount of RPA strand melting with MgCl2 and
ATP. We modified the 30-nt flap substrate, used in Fig. 6A, to
create an AT-rich region in the annealed portion of the labeled
primer (see Table 1). The GC content in the annealed region
was lowered from 52 to 33%. This AT-rich substrate was then
used tomeasure RPA strandmelting in Fig. 6,C andD.We first
tested RPA strand melting without MgCl2 and ATP present
(Fig. 6C), for comparison with the previous flap substrate used
in Fig. 6A. We saw a significant increase in strand unwinding
(compare Fig. 6, A and C). RPA unwinding activity was then
tested in the presence of 2 mMMgCl2 and 1 mM ATP (Fig. 6D).
FIGURE5.Dna2cleavagepatterns inthepresenceofRPA.Reactionswereperformedwith5fmolof the30-nt flap
substrate (D4:U1:T1).A, cleavagebywild typeDna2 (10 fmol)wasmeasuredona5-radiolabeled flap substratewith
increasing amounts of RPA (10, 50, 100, and 500 fmol). B, cleavage reactions were performed as in A, except a
3-radiolabeled flap substratewas used.C, Dna2K1080E (5 fmol), a helicase-deficientmutant,was used tomeasure
cleavage activity with increasing amounts of RPA (10, 50, 100, and 200 fmol), in the absence of ATP, using the
3-radiolabeled flap substrate. In all gels, lanes 1–3 are the substrate alone, substratewithRPA (500 fmol) alone, and
substratewithDna2alone, respectively. Percent cleavage is definedas (cleaved/(cleaveduncleaved))100. The
substrates used are depicted above the gel with the asterisk indicating the site of the 32P radiolabel.
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Although RPA strand melting was lowered, we still saw a sig-
nificant amount of substrate melting on the AT-rich substrate.
Based on these findings, we propose that RPA strand melting
activity can facilitate flap elongation under physiological
conditions.
RPA Removal of DNA Secondary Structure Promotes Dna2
Cleavage—RPA strand melting was previously shown to aid
Dna2 cleavage activity (21). In the study, a flap substrate able to
form a 10-bp duplex in the central region of the flap was used to
show that RPA improved Dna2 cleavage past the duplex.
Because these results were not compared with results of an
unstructured flap, we tested a 30-nt poly(dT) flap substrate to
determine whether stimulation was solely due to RPA strand
melting activity. The unstructured flap was compared with two
structured flaps, one predicted to form a 6-bp duplex (G 
3.3) and another with a potential 18-bp duplex (G  21)
(see Table 1). These latter substrates also contain a GC content
of 75% in the annealed portion of the labeled flap-primer,
which inhibited strand melting of the annealed region by RPA
(data not shown).
Dna2 and increasing amounts of RPA were incubated with
the flaps and the cleavage products were analyzed by denatur-
ing PAGE (Fig. 7). The addition of RPA produced little increase
in the amount of Dna2 cleavage of both the unstructured flap
and the 18-bp duplex, whereas the 6-bp duplex showed a sig-
nificant increase in cleavage activity (compare Fig. 7, lanes 4–7,
11–14, and 18–21). Consideration of the expected melting
properties of RPA provides a plausible explanation for these
results. The unstructured flap has no secondary structure to
hinder movement or cleavage by Dna2, and so RPA would not
stimulate Dna2. The 18-bp duplex structure may be too stable
for RPA to fully melt, preventing RPA from stimulating Dna2.
The 6-bp duplex structure may be just the right stability for
RPA melting such that it promotes Dna2 cleavage activity.
The RPA-induced shift in cleavage pattern, apparent with
the 18-bp duplex substrate, can be explained by partial melting
of the duplex by RPA followed by Dna2 cleavage (Fig. 7, lanes
17–21). Despite the lack of increased cleavage product on the
unstructured flap, the addition of RPA did shift the final Dna2
cleavage site further down the flap (Fig. 7, lanes 4–7) and
decreased the size of the first product (data not shown), similar
to the results in Fig. 5. Based on these findings, we can conclude
that the removal of structure is amajor, but not complete deter-
minant of RPA effects on Dna2 cleavage activity. This idea is
consistent with other reports of increased Dna2 cleavage activ-
ity by RPA, in which the flaps used were predicted to contain
DNA secondary structure (9, 10, 42, 43). Additionally, the poor
RPA stimulation ofDna2 in Fig. 5 is likely explained by theweak
DNA secondary structure of the 30-nt flap substrate (G 
1.2). However, RPA stimulation of Dna2 does appear to be
limited to the strand melting capacity of RPA, because stimu-
lation was not observed on the more stable 18-nt duplex (Fig.
7A, lanes 17–21).
DISCUSSION
In one proposed pathway of eukaryotic Okazaki fragment
processing, the 5-end region of the fragment is displaced into a
flap long enough to bind RPA (9, 42, 43). The RPA stimulates
FIGURE6.RPAstrandmeltingactivityallowsDna2cleavagepast thebase
of the flap. Non-denaturing PAGE was performed to measure the strand
melting activity of RPA. A, increasing amounts of RPA (50, 100, 200, and 500
fmol) and5 fmol of flap substratewere incubated in the absenceofMgCl2 and
ATP (lanes 2–5). The 30-nt substrate (D4:U1:T1) used was the same as in Fig.
5B.B, anunwindingassaywasperformedas inA,except 2mMMgCl2 and1mM
ATP were included in the reaction buffer. C, an unwinding assay was per-
formedas inA, except theGCcontentof the30-nt substratewas lowered from
52 to 33% (D5:U1:T2) in the annealed region of the primer (see Table 1).D, an
unwinding assay was performed as in C, except 2 mM MgCl2 and 1 mM ATP
were included in the reaction buffer. In all cases, lane 1 represents the sub-
strate alone. Percent unwound is defined as (unwound/(unwound 
annealed)) 100. Substrate and product bands are identified. The substrate
is depicted above the gel in Awith the asterisk indicating the site of the 3-32P
radiolabel.
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the tracking and cleavage activity of the Dna2 helicase/nucle-
ase, which cleaves the flap to a length that does not support RPA
binding, allowing FEN1 access. In this study, we explored the
mechanism by which Dna2 enters and cleaves an RPA-coated
flap. Using a nuclease-defective mutant of Dna2 (E675A), we
showed that Dna2 removes RPA before the flap is reduced in
length. This result is striking because RPA binds DNA with
such high affinity and, in fact, binds more tightly than Dna2
(Table 2). In addition, we have examined the mechanism of
RPA stimulation by Dna2 and found that RPA strand melting
activity increases Dna2 cleavage through the removal of the
DNA secondary structure.
Dna2 and RPA have been shown to interact physically and
RPA stimulates Dna2 cleavage activity (9, 22). Based on these
observations, our initial hypothesis was thatDna2 binds to flaps
coated with RPA, allowing the Dna2 and RPA to bind each
other. Because Dna2 requires tracking to cleave the flap, we
envisioned that Dna2would enter at the 5-end and track down
the flap associating with successive RPA molecules. The inter-
actions would stimulate Dna2 to cleave the flap, releasing a
mixture of RPA-bound flap segments, free RPA, and free DNA.
Following cleavage by Dna2, the remaining short flap would be
free of RPA for subsequent tracking and cleavage by FEN1.
Instead, by using the Dna2 cleavage mutant, we found that
Dna2 dissociates RPA independent of the cleavage process (Fig.
1).Webelieve that this is indicative of anRPA remodeling event
caused by Dna2, which lowers the binding affinity of RPA.
Because our reactions were done with a nuclease-defective
Dna2 mutant, we cannot exclude the possibility that concur-
rent Dna2 cleavage activity aids in further destabilization of
RPA binding.
A major function of RPA within the cell is to coat ssDNA,
reducing its melting temperature, thus preventing the forma-
tion of secondary structure and reannealing (23–25). RPAmust
then be removed or displaced to permit other proteins access to
the DNA. Fanning and colleagues (27, 44) have proposed that
displacement occurs through protein-protein interactions,
which remodel the conformation of RPA from an extended
(high affinity) to a more compact (low affinity) form. The
weakly bound form of RPA is then readily displaced by other
proteins, allowing enzyme access to the DNA. We believe that
Dna2 interacts with RPA in a similar manner to elicit its disso-
ciation. Additionally, we have shown that RPA stimulates Dna2
by the removal of DNA secondary structure (Fig. 7). For this to
occur, RPA must be displaced coordinately with the nearby
binding of Dna2. This is the only way that we can visualize for
RPA to relinquish the DNA to Dna2 before reformation of sta-
ble secondary structures.
Moreover, the ability of Dna2 to quantitatively dissociate
RPAmay require a polymer structure unique to a flap substrate,
because Dna2 does not remove RPA from ssDNA but instead
forms an RPA-Dna2 complex (Fig. 4). Possibly, Dna2 must also
be conformationally altered by initial interaction with the base
of the flap, before it can accomplish efficient removal of RPA.
Additional studies are required to elucidate why binding and
dissociation of RPA by Dna2 did not occur on ssDNA but these
results indicate the importance of the flap structure.
Consistentwith this interpretation,we discovered that track-
ing of Dna2 on the flap is not required for RPA removal (Fig. 3).
We previously reported thatDna2 binds to a flap substrate even
when tracking is blocked by a biotin-streptavidin at the flap
5-end (34).WhenDna2 binds in this non-trackingmode cleav-
age cannot occur but the Dna2 can still clear the flap of RPA,
thus allowing cleavage by either another Dna2 molecule or
FEN1. This would allow more rapid progression toward the
final product, even if Dna2 binds the flap in the non-tracking
mode. We have also considered that both Dna2 and RPA are
proposed to be involved in overlapping cellular pathways, such
as DNA repair, recombination, and telomere maintenance (20,
27–29, 45–48). Dissociation of RPA by Dna2 could extend to
these other pathways in which RPA removal is necessary for
further processing of the DNA.
To better understand how RPA alters the movements and
nuclease functions of Dna2 on the flap, we conducted a detailed
analysis of theDna2 cleavage pattern in the presence of RPA.As
long flaps arise during lagging strand replication, they have an
increasing propensity to formDNA secondary structure.When
this structure becomes stable enough to interfere with tracking,
FIGURE 7.Dna2 cleavage activity in the presence of RPA on unstructured
and structured flap substrates.Dna2 (10 fmol) cleavage activity was meas-
ured by denaturing PAGE with increasing amounts of RPA (10, 50, 100, and
200 fmol) and 5 fmol of substrate. Lanes 1, 8, and 15 are substrate alone. Lanes
2, 9, and 16 are substratewith RPA (200 fmol) alone and lanes 3, 10, and 17 are
substratewithDna2 (10 fmol) alone. Lanes 1–7 contain apoly(dT) sequence in
the flap region of the substrate (D6:U2:T3). Lanes 8–14 contain a 6-nt duplex
in the flap region (D7:U2:T3) with lengths a 6 nt; b 6 nt; c 4 nt; and d
10 nt. Lanes 15–21 contain an 18-nt duplex in the flap region of the substrate
(D8:U2:T3) with lengths a 12 nt; b 18 nt; c 6 nt; and d 33 nt. Percent
cleavage is defined as (cleaved/(cleaved uncleaved)) 100. The substrates
are depicted above the gel with the asterisk indicating the site of the 3-32P
radiolabel.
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it can inhibit the nuclease activity of both Dna2 and FEN1.
Dna2 helicase activity has previously been shown to provide
little aid to tracking on structured flap substrates. In one study,
Dna2 helicase function was shown to enhance Dna2 cleavage
past a predicted 10-nt duplex in the flap region, which blocked
cleavage by Dna2 (21). Although cleavage past the duplex was
increased, the predominant products still occurred before the
duplex region. In another study by our group, Dna2 helicase
activity provided only minor stimulation of Dna2 cleavage past
the predicted duplex regions in the flaps, as the amount of
structure increased (38). Furthermore, we have shownhere that
cleavage by Dna2 alone is significantly reduced on a structured
flap, containing a predicted 6-nt duplex, compared with cleav-
age on an unstructured flap (Fig. 7). These results indicate that
Dna2 helicase activity alone is not sufficient to remove stable
DNA secondary structure.
In our current work, the presence of RPA stimulated Dna2
cleavage on the predicted 6-nt duplex flap but not an unstruc-
tured flap (Fig. 7). RPA not only increased Dna2 cleavage but
shifted cleavage further down the flap past the duplex. These
results allow us to attribute Dna2 stimulation to relief of DNA
secondary structure by RPA. Although, when a flap with a pre-
dicted 18-nt duplex was used, Dna2 cleavage was not increased,
suggesting that RPA strand melting capacity is limited.
Although RPA strandmeltingmay not fully unwind very sta-
ble structures, one could imagine that in vivoRPAwould hinder
such stable structures from forming. Reconstitution studies of
Okazaki fragment processing have shown that a small fraction
of flaps formed dynamically during lagging strand synthesis
escape FEN1 cleavage and reach a length to which RPA can
bind (14). Because RPA is an abundant protein within the
nucleus and RPA binds ssDNA very rapidly (27–29), flaps not
readily cleaved by FEN1 would be stably bound by RPA once
they reach an adequate length. In this sense, RPA binding pre-
pares the flap forDna2 cleavage and stimulates cleavage activity
by the removal of secondary structure. The cooperative action
of RPA strand melting and the additional helicase activity of
Dna2 may also be required if flaps have already formed stable
secondary structure prior to RPA binding.
From these findings, we have developed amodel of how RPA
andDna2 interact during Okazaki fragment processing (Fig. 8).
When long flaps arise, they have a greater tendency to form
DNA secondary structure. In the absence of RPA, Dna2 cleav-
age would be inhibited on these structured flaps. Binding by
RPA would melt out the structure in the flap. Our current
results show that Dna2 requires a flap structure for facile disso-
ciation of RPA. Based on these observations, we propose that
Dna2 recognizes the flap and begins the tracking process. It
then dissociates RPA, moving through the ssDNA before the
reformation ofDNA secondary structure. During this process it
cuts the flap to successively shorter lengths. Following cleavage
by Dna2, the remaining short flap, which RPA cannot bind,
would then be subject to cleavage by FEN1, creating a nick for
ligation.
We must also reconcile this model with the observation that
Dna2 can dissociate RPA without tracking. Dna2 must track to
cleave, and must acquire the unfolded DNA at the moment of
RPA dissociation. In view of these facts, it is reasonable to con-
clude that RPA dissociation is accomplished during tracking.
Blocked tracking is an unnatural condition during Okazaki
fragment processing. The fact that RPA dissociation can still be
accomplished reveals a feature of the dissociation mechanism,
but may not represent the coordinated interactions that occur
when tracking is allowed.
An additional value of the facile dissociation of RPA by Dna2
is the likelihood that Dna2 slows RPA-promoted flap elonga-
tion. We and the Seo group (9, 14) have proposed that the two-
nuclease pathway for flap removal has evolved to cleave flaps
that become too long for processing by FEN1 alone. Although
RPA strandmelting activity would aid Dna2 in flap cleavage, an
additional consequence of strand melting is the potential for
further flap elongation. RPA strandmelting capacitywas shown
to bind to AT-rich regions of the SV40 genome and catalyze
unwinding of the DNA (40). Additionally, we have demon-
strated that RPA stimulates Dna2 cleavage into the annealed
portion of the primer, as a consequence of RPA strand melting
activity (Fig. 5). RPA-promoted strand melting, as assessed by
RPA unwinding, was increased when AT-rich downstream
double-stranded regions were examined and diminished when
AT content was minimized. We suggest that Dna2-directed
dissociation of RPAwould help to slow flap displacement, min-
imizing unnecessary degradation of the DNA portion of Oka-
zaki fragments during processing.
Finally, the interaction between RPA andDna2 appears to be
specific to proteins from the same species. Previous analysis of
FIGURE8.Amodel of theproposedRPA/Dna2 interactionduringOkazaki
fragment processing. Strand displacement synthesis by pol  creates flap
intermediates that can become long and form DNA secondary structure.
This structure inhibits cleavage activity by Dna2 or FEN1. RPA then uses its
strand melting capacity to remove the structure and bind the flap. Dna2
tracking is then employed to remove RPA from the flap and cleave. Finally,
the remaining RPA-free flap is cleaved by FEN1 to create a nick for ligation
by DNA Ligase I.
RPA andDna2 in Okazaki Fragment Processing
31364 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 46•NOVEMBER 14, 2008
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Novem
ber 8, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
Dna2 cleavage reactions with RPA revealed that RPA of the
same species stimulated Dna2 cleavage, but when homologues
of RPA and Dna2 from different species were tested together
Dna2 cleavage was inhibited (31). We were able to reproduce
this phenomenon using the 53-nt flap substrate with hRPA and
yeast Dna2 (Fig. 2A). We extended this analysis to show that
dissociation of bound hRPA by yeast Dna2 is inhibited suggest-
ing that dissociation of the flap-bound RPA is required for
cleavage. Even hRPA, which shares 30% identical and 45%
similar sequence homology with S. cerevisiae RPA (28), is
unable to be dissociated by Dna2 (Fig. 2B). This contrasts with
the facile dissociation of RPA seen when yeast RPA and Dna2
were tested (see Fig. 1). Importantly, this result is also further
confirmation that Dna2-promoted dissociation of RPA is a very
specific phenomenon, and not a consequence of a simple bind-
ing competition. Specificity is additionally supported by results
with the E. coli homolog of RPA, single-stranded binding pro-
tein, which was found to inhibit yeast Dna2 cleavage (9). Taken
together, we can conclude that Dna2 specifically interacts with
RPA to facilitate dissociation followed by Dna2 cleavage.
In conclusion, we have more closely defined the interactions
between RPA and Dna2. Our findings show that RPA strand
melting capacity can relieve the DNA secondary structure in
the flap to facilitate rapid and efficient tracking and cleavage by
Dna2. Concurrently, Dna2 dissociates the flap-bound RPA to
access the flap for cleavage, leaving a short RPA-free flap. FEN1
cleavage then creates a nicked product for subsequent ligation
and fragment joining. In this fashion, Dna2 and RPA have
evolved to coordinate their functions to ensure proper primer
removal during Okazaki fragment processing.
Acknowledgments—We thank Drs. Sara Binz andMarc Wold for the
purified yeast and human RPA proteins. In addition, we thank mem-
bers of the Bambara and Campbell laboratories for valuable discus-
sion and critical review of the manuscript.
REFERENCES
1. Kornberg, A., and Baker, T. A. (1992) DNA Replication, 2nd Ed., pp.
140–144, W. H. Freeman, New York
2. Rossi, M. L., Purohit, V., Brandt, P. D., and Bambara, R. A. (2006) Chem.
Rev. 106, 453–473
3. Shevelev, I. V., and Hubscher, U. (2002) Nat. Rev. Mol. Cell. Biol. 3,
364–376
4. Ayyagari, R., Gomes, X. V., Gordenin, D. A., and Burgers, P. M. (2003)
J. Biol. Chem. 278, 1618–1625
5. Maga, G., Frouin, I., Spadari, S., and Hubscher, U. (2001) J. Biol. Chem.
276, 18235–18242
6. Podust, V. N., Podust, L.M., Goubin, F., Ducommun, B., andHubscher, U.
(1995) Biochemistry 34, 8869–8875
7. Jin, Y. H., Ayyagari, R., Resnick,M. A., Gordenin, D. A., and Burgers, P.M.
(2003) J. Biol. Chem. 278, 1626–1633
8. Liu, Y., Kao, H. I., and Bambara, R. A. (2004) Annu. Rev. Biochem. 73,
589–615
9. Bae, S. H., Bae, K. H., Kim, J. A., and Seo, Y. S. (2001)Nature 412, 456–461
10. Bae, S. H., and Seo, Y. S. (2000) J. Biol. Chem. 275, 38022–38031
11. Arunkumar, A. I., Stauffer, M. E., Bochkareva, E., Bochkarev, A., and Cha-
zin, W. J. (2003) J. Biol. Chem. 278, 41077–41082
12. Bochkareva, E., Korolev, S., Lees-Miller, S. P., and Bochkarev, A. (2002)
EMBO J. 21, 1855–1863
13. Henricksen, L. A., Umbricht, C. B., and Wold, M. S. (1994) J. Biol. Chem.
269, 11121–11132
14. Rossi, M. L., and Bambara, R. A. (2006) J. Biol. Chem. 281, 26051–26061
15. Budd, M. E., and Campbell, J. L. (1995) Proc. Natl. Acad. Sci. U. S. A 92,
7642–7646
16. Kuo, C., Nuang, H., andCampbell, J. L. (1983) Proc. Natl. Acad. Sci. U. S. A
80, 6465–6469
17. Bae, S. H., Choi, E., Lee, K. H., Park, J. S., Lee, S. H., and Seo, Y. S. (1998)
J. Biol. Chem. 273, 26880–26890
18. Budd, M. E., and Campbell, J. L. (1997)Mol. Cell. Biol. 17, 2136–2142
19. Masuda-Sasa, T., Polaczek, P., and Campbell, J. L. (2006) J. Biol. Chem.
281, 38555–38564
20. Budd, M. E., Tong, A. H., Polaczek, P., Peng, X., Boone, C., and Campbell,
J. L. (2005) PLoS Genet 1, e61
21. Bae, S. H., Kim, D. W., Kim, J., Kim, J. H., Kim, D. H., Kim, H. D., Kang,
H. Y., and Seo, Y. S. (2002) J. Biol. Chem. 277, 26632–26641
22. Bae, K. H., Kim, H. S., Bae, S. H., Kang, H. Y., Brill, S., and Seo, Y. S. (2003)
Nucleic Acids Res. 31, 3006–3015
23. Brill, S. J., and Stillman, B. (1991) Genes Dev. 5, 1589–1600
24. Heyer, W. D., Rao, M. R., Erdile, L. F., Kelly, T. J., and Kolodner, R. D.
(1990) EMBO J. 9, 2321–2329
25. Haring, S. J.,Mason, A. C., Binz, S. K., andWold,M. S. (2008) J. Biol. Chem.
283, 19095–19111
26. Wold, M. S., and Kelly, T. (1988) Proc. Natl. Acad. Sci. U. S. A 85,
2523–2527
27. Fanning, E., Klimovich, V., and Nager, A. R. (2006) Nucleic Acids Res. 34,
4126–4137
28. Wold, M. S. (1997) Annu. Rev. Biochem. 66, 61–92
29. Iftode, C., Daniely, Y., and Borowiec, J. A. (1999) Crit. Rev. Biochem. Mol.
Biol. 34, 141–180
30. Kao, H. I., Campbell, J. L., and Bambara, R. A. (2004) J. Biol. Chem. 279,
50840–50849
31. Kim, D. H., Lee, K. H., Kim, J. H., Ryu, G. H., Bae, S. H., Lee, B. C., Moon,
K. Y., Byun, S. M., Koo, H. S., and Seo, Y. S. (2005) Nucleic Acids Res. 33,
1372–1383
32. Budd, M. E., Choe, W., and Campbell, J. L. (2000) J. Biol. Chem. 275,
16518–16529
33. Sibenaller, Z. A., Sorensen, B. R., andWold, M. S. (1998) Biochemistry 37,
12496–12506
34. Stewart, J. A., Campbell, J. L., and Bambara, R. A. (2006) J. Biol. Chem. 281,
38565–38572
35. Mathews, D.H., Sabina, J., Zuker,M., andTurner, D.H. (1999) J.Mol. Biol.
288, 911–940
36. Zuker, M. (2003) Nucleic Acids Res. 31, 3406–3415
37. Kim, C., Paulus, B. F., and Wold, M. S. (1994) Biochemistry 33,
14197–14206
38. Kao, H. I., Veeraraghavan, J., Polaczek, P., Campbell, J. L., and Bambara,
R. A. (2004) J. Biol. Chem. 279, 15014–15024
39. Georgaki, A., Strack, B., Podust, V., and Hubscher, U. (1992) FEBS Lett.
308, 240–244
40. Treuner, K., Ramsperger, U., and Knippers, R. (1996) J. Mol. Biol. 259,
104–112
41. Georgaki, A., and Hubscher, U. (1993) Nucleic Acids Res. 21, 3659–3665
42. Kao, H. I., Henricksen, L. A., Liu, Y., and Bambara, R. A. (2002) J. Biol.
Chem. 277, 14379–14389
43. Masuda-Sasa, T., Imamura, O., and Campbell, J. L. (2006) Nucleic Acids
Res. 34, 1865–1875
44. Arunkumar, A. I., Klimovich, V., Jiang, X., Ott, R. D., Mizoue, L., Fanning,
E., and Chazin, W. J. (2005) Nat. Struct. Mol. Biol. 12, 332–339
45. Smith, J., Zou, H., and Rothstein, R. (2000) Biochimie (Paris) 82, 71–78
46. Schramke, V., Luciano, P., Brevet, V., Guillot, S., Corda, Y., Longhese,
M. P., Gilson, E., and Geli, V. (2004) Nat. Genet. 36, 46–54
47. Salas, T. R., Petruseva, I., Lavrik, O., Bourdoncle, A., Mergny, J. L., Favre,
A., and Saintome, C. (2006) Nucleic Acids Res. 34, 4857–4865
48. Choe, W., Budd, M., Imamura, O., Hoopes, L., and Campbell, J. L. (2002)
Mol. Cell. Biol. 22, 4202–4217
RPA andDna2 in Okazaki Fragment Processing
NOVEMBER 14, 2008•VOLUME 283•NUMBER 46 JOURNAL OF BIOLOGICAL CHEMISTRY 31365
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Novem
ber 8, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
